Proposed changes to rules governing the commercialization of technologies developed with federal funding prompts significant stakeholder feedback.
Proposed changes to rules governing the commercialization of technologies developed with federal funding prompts significant stakeholder feedback.
Cell-based therapies are moving medical treatments forward, but intellectual property uncertainties may delay progress.